Promises and pitfalls in implementation science from the perspective of US-based researchers: learning from a pre-mortem.

Implementation science Opportunities Pre-mortem exercise Threats

Journal

Implementation science : IS
ISSN: 1748-5908
Titre abrégé: Implement Sci
Pays: England
ID NLM: 101258411

Informations de publication

Date de publication:
13 08 2022
Historique:
received: 10 11 2021
accepted: 20 07 2022
entrez: 13 8 2022
pubmed: 14 8 2022
medline: 17 8 2022
Statut: epublish

Résumé

Implementation science is at a sufficiently advanced stage that it is appropriate for the field to reflect on progress thus far in achieving its vision, with a goal of charting a path forward. In this debate, we offer such reflections and report on potential threats that might stymie progress, as well as opportunities to enhance the success and impact of the field, from the perspective of a group of US-based researchers. Ten mid-career extramurally funded US-based researchers completed a "pre-mortem" or a group brainstorming exercise that leverages prospective hindsight to imagine that an event has already occurred and to generate an explanation for it - to reduce the likelihood of a poor outcome. We came to consensus on six key themes related to threats and opportunities for the field: (1) insufficient impact, (2) too much emphasis on being a "legitimate science," (3) re-creation of the evidence-to-practice gap, (4) difficulty balancing accessibility and field coherence, (5) inability to align timelines and priorities with partners, and (6) overly complex implementation strategies and approaches. We submit this debate piece to generate further discussion with other implementation partners as our field continues to develop and evolve. We hope the key opportunities identified will enhance the future of implementation research in the USA and spark discussion across international groups. We will continue to learn with humility about how best to implement with the goal of achieving equitable population health impact at scale.

Sections du résumé

BACKGROUND
Implementation science is at a sufficiently advanced stage that it is appropriate for the field to reflect on progress thus far in achieving its vision, with a goal of charting a path forward. In this debate, we offer such reflections and report on potential threats that might stymie progress, as well as opportunities to enhance the success and impact of the field, from the perspective of a group of US-based researchers.
MAIN BODY
Ten mid-career extramurally funded US-based researchers completed a "pre-mortem" or a group brainstorming exercise that leverages prospective hindsight to imagine that an event has already occurred and to generate an explanation for it - to reduce the likelihood of a poor outcome. We came to consensus on six key themes related to threats and opportunities for the field: (1) insufficient impact, (2) too much emphasis on being a "legitimate science," (3) re-creation of the evidence-to-practice gap, (4) difficulty balancing accessibility and field coherence, (5) inability to align timelines and priorities with partners, and (6) overly complex implementation strategies and approaches.
CONCLUSION
We submit this debate piece to generate further discussion with other implementation partners as our field continues to develop and evolve. We hope the key opportunities identified will enhance the future of implementation research in the USA and spark discussion across international groups. We will continue to learn with humility about how best to implement with the goal of achieving equitable population health impact at scale.

Identifiants

pubmed: 35964095
doi: 10.1186/s13012-022-01226-3
pii: 10.1186/s13012-022-01226-3
pmc: PMC9375077
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

55

Subventions

Organisme : NCI NIH HHS
ID : P50 CA244690
Pays : United States

Informations de copyright

© 2022. The Author(s).

Références

Cancer Causes Control. 2021 Mar;32(3):221-230
pubmed: 33392908
Implement Sci Commun. 2021 Jul 17;2(1):78
pubmed: 34274027
J Public Health (Oxf). 2018 Mar 1;40(suppl_1):i64-i70
pubmed: 29538721
BMC Med Res Methodol. 2017 Dec 06;17(1):161
pubmed: 29207955
BMC Med Res Methodol. 2017 Mar 4;17(1):38
pubmed: 28259155
BMJ. 2021 Jan 18;372:m3721
pubmed: 33461967
Healthc (Amst). 2021 Jun;8 Suppl 1:100455
pubmed: 34175093
Am J Public Health. 2009 Sep;99(9):1576-83
pubmed: 19608941
Implement Sci Commun. 2021 Jan 15;2(1):9
pubmed: 33451364
Implement Sci. 2019 Dec 11;14(1):103
pubmed: 31823787
Front Public Health. 2019 Jun 18;7:158
pubmed: 31275915
J Sch Psychol. 2019 Oct;76:66-77
pubmed: 31759470
Clin Infect Dis. 2020 Dec 31;71(11):2993-2995
pubmed: 32436576
Learn Health Syst. 2019 Sep 26;4(1):e10201
pubmed: 31989028
Implement Sci. 2017 Nov 3;12(1):125
pubmed: 29100551
Psychiatry Res. 2020 Jan;283:112433
pubmed: 31202612
Ethn Dis. 2021 Jan 21;31(1):133-138
pubmed: 33519163
Implement Sci. 2021 Mar 19;16(1):28
pubmed: 33740999
Implement Sci. 2020 Jun 8;15(1):42
pubmed: 32513292
Am J Public Health. 2010 Apr 1;100 Suppl 1:S40-6
pubmed: 20147663
Adm Policy Ment Health. 2016 Sep;43(5):783-798
pubmed: 26474761
BMJ Qual Saf. 2019 May;28(5):416-423
pubmed: 30852557
Health Educ Behav. 2017 Dec;44(6):835-838
pubmed: 29025265
Prev Chronic Dis. 2018 Dec 20;15:E162
pubmed: 30576272
J Med Humanit. 2020 Sep;41(3):379-394
pubmed: 31965463
Annu Rev Public Health. 2015 Mar 18;36:507-23
pubmed: 25785894
J Clin Transl Sci. 2019 Jul 29;4(3):152-158
pubmed: 32695482
Psychiatry Res. 2019 Oct;280:112516
pubmed: 31437661
Implement Sci. 2015 Aug 07;10:109
pubmed: 26249843
Implement Res Pract. 2021 Nov 26;2:26334895211049482
pubmed: 37089985
J Oncol Pract. 2018 Jun;14(6):335-340
pubmed: 29750579
Ann Behav Med. 2011 Apr;41(2):208-26
pubmed: 21132416
Implement Sci Commun. 2020 Feb 26;1:17
pubmed: 32885179
Implement Sci. 2020 Oct 30;15(1):97
pubmed: 33126909
J Child Psychol Psychiatry. 2019 Apr;60(4):430-450
pubmed: 30144077
Front Public Health. 2019 Jan 22;7:3
pubmed: 30723713
Implement Sci. 2019 Mar 12;14(1):26
pubmed: 30866982
BMC Med Res Methodol. 2020 Jun 26;20(1):169
pubmed: 32590940
Lancet. 2017 Apr 8;389(10077):1453-1463
pubmed: 28402827
Cancer Causes Control. 2018 Mar;29(3):363-369
pubmed: 29417296
Ann Am Thorac Soc. 2021 Feb;18(2):300-307
pubmed: 33522870
Transl Behav Med. 2016 Jun;6(2):317-28
pubmed: 27357001
Int J Behav Med. 2015 Jun;22(3):283-91
pubmed: 24852184
Psychiatr Serv. 2013 Jun;64(6):509-11
pubmed: 23728600
Health Aff (Millwood). 2021 Jan;40(1):42-52
pubmed: 33211536
J Clin Transl Sci. 2021 Jul 05;5(1):e147
pubmed: 34527287
Front Public Health. 2020 Jul 03;8:245
pubmed: 32719761
J Clin Epidemiol. 2018 Aug;100:92-102
pubmed: 29660481
Implement Sci. 2013 Dec 01;8:139
pubmed: 24289295
Syst Rev. 2020 Dec 3;9(1):277
pubmed: 33272313
Implement Sci. 2015 Jan 08;10:1
pubmed: 25567289
Fam Pract. 2008 Dec;25 Suppl 1:i20-4
pubmed: 18794201
J Invest Dermatol. 2018 Jan;138(1):228-230
pubmed: 28843488
Transl Behav Med. 2017 Sep;7(3):624-635
pubmed: 27142266
Implement Res Pract. 2020 Sep 02;1:2633489520949151
pubmed: 34192265
BMJ. 2014 Mar 07;348:g1687
pubmed: 24609605
Transl Behav Med. 2021 Mar 16;11(2):669-675
pubmed: 32145023
Front Public Health. 2020 May 27;8:194
pubmed: 32528921
Am J Public Health. 2015 Jan;105(1):49-57
pubmed: 25393182
Worldviews Evid Based Nurs. 2019 Oct;16(5):332-334
pubmed: 31603625
Ann Stat. 2021 Apr;49(2):793-819
pubmed: 35510045
J Eval Clin Pract. 2007 Apr;13(2):161-8
pubmed: 17378860
Implement Sci Commun. 2020;1:
pubmed: 32391524
J Gen Intern Med. 2020 Dec;35(12):3675-3680
pubmed: 32472492
JAMA Psychiatry. 2021 Sep 1;78(9):941-942
pubmed: 34076686
Am J Prev Med. 2007 May;32(5 Suppl):S112-8
pubmed: 17466815
BMC Health Serv Res. 2020 May 21;20(1):449
pubmed: 32438909
Implement Sci Commun. 2021 Jun 29;2(1):70
pubmed: 34187595
Front Public Health. 2018 May 07;6:136
pubmed: 29868544
Implement Sci. 2012 Apr 24;7:38
pubmed: 22531013
J Community Psychol. 2018 Sep;46(7):941-952
pubmed: 30565736
J Eval Clin Pract. 2022 Dec;28(6):991-1002
pubmed: 34268832
Implement Sci. 2021 Jul 2;16(1):67
pubmed: 34215286
Implement Sci. 2017 Mar 4;12(1):30
pubmed: 28259168
J Consult Clin Psychol. 2009 Jun;77(3):566-79
pubmed: 19485596
BMJ. 2017 Mar 6;356:i6795
pubmed: 28264797
Am J Prev Med. 2013 Aug;45(2):237-43
pubmed: 23867032
PLoS Med. 2016 Apr 12;13(4):e1001991
pubmed: 27070913
Front Public Health. 2019 Nov 08;7:325
pubmed: 31781528
Implement Sci Commun. 2021 Apr 23;2(1):44
pubmed: 33892822
Lancet. 2020 Feb 15;395(10223):476-477
pubmed: 32061280
BMC Med. 2019 May 7;17(1):88
pubmed: 31064388
Ethn Dis. 2021 Jan 21;31(1):119-132
pubmed: 33519162
JAMA. 2016 May 10;315(18):1941-2
pubmed: 27163980
Implement Sci. 2019 Jun 21;14(1):67
pubmed: 31226992
BMC Health Serv Res. 2020 Mar 12;20(1):190
pubmed: 32164706
Implement Sci. 2019 Jul 15;14(1):72
pubmed: 31307489
Med J Aust. 2019 Nov;211(10):444-446.e1
pubmed: 31656046
Implement Sci. 2020 Apr 16;15(1):21
pubmed: 32299461
Am Psychol. 2020 Nov;75(8):1130-1145
pubmed: 33252950
J Clin Transl Sci. 2021 Jul 12;5(1):e151
pubmed: 34527291
J Clin Epidemiol. 2017 May;85:3-11
pubmed: 28341367
Implement Res Pract. 2020 May 21;1:0020764020925994
pubmed: 36915854
Prev Sci. 2020 May;21(4):545-556
pubmed: 32020489
Adm Policy Ment Health. 2011 Mar;38(2):65-76
pubmed: 20957426
Front Public Health. 2019 Mar 29;7:64
pubmed: 30984733
Am J Prev Med. 2017 Mar;52(3 Suppl 3):S322-S329
pubmed: 28215389
Ethn Dis. 2021 May 20;31(Suppl 1):357-364
pubmed: 34045837
Ethn Dis. 2021 May 20;31(Suppl 1):375-388
pubmed: 34045839
Clin Transl Sci. 2018 Jan;11(1):77-84
pubmed: 28887873
Public Health Rep. 2014 Jan-Feb;129 Suppl 2:5-8
pubmed: 24385658
Implement Sci. 2015 Feb 12;10:21
pubmed: 25889199
Front Public Health. 2020 May 12;8:134
pubmed: 32478025
J Behav Health Serv Res. 2017 Apr;44(2):177-194
pubmed: 26289563
Implement Sci. 2014 Dec 18;9:168
pubmed: 25518730
Prev Sci. 2019 Aug;20(6):914-935
pubmed: 31152328
Bull World Health Organ. 2017 Feb 1;95(2):87
pubmed: 28250505
Acad Med. 2005 Apr;80(4):317-21
pubmed: 15793012
Ethn Dis. 2009 Autumn;19(4 Suppl 6):S6-3-7
pubmed: 20088076
BMC Med Res Methodol. 2018 Nov 27;18(1):153
pubmed: 30482159
BMC Med Educ. 2014 Jan 28;14:18
pubmed: 24472088
PLoS One. 2010 May 04;5(5):e10355
pubmed: 20463949
Transl Behav Med. 2021 Aug 13;11(8):1617-1625
pubmed: 33904908
BMJ Open. 2021 Oct 18;11(10):e053474
pubmed: 34663668
Implement Sci. 2010 Feb 12;5:16
pubmed: 21080976

Auteurs

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH